Experts in the Intricacies of Cell Therapy Development
End-to-end experience in delivering a broad range of cell therapies
Contact us
Precision was born from a desire to support innovators in precision medicine. Your cell therapy project will be enriched by our collective experience in cell therapy development. Our services span from award-winning CRO to comprehensive biomarker assay services to pioneering builds of GMP compliant cell therapy facilities from 5000 to 500,000 square feet.
Helping innovators deliver on the promise of cell therapy
Cell therapy development is at the forefront of advanced therapeutic modalities, especially in oncology research, but the intricacies can complicate the development process.
Precision’s experience developing a broad range of cell therapies, including CAR T cells, stem cells, autologous and allogeneic products, and tumor-infiltrating lymphocytes, gives us insight into the challenges of cell therapy as a whole, as well as how development of each of these cell types differ. We understand the isues each program can face and our integrated, multidisciplinary team can create a bespoke solution appropriate for your project. We are working with leaders in cell therapy innovation and take pride in the FDA approvals we’ve supported. Bringing breakthrough treatments to patients in need is our purpose and passion.
25
countries with cell therapy trials
10
cell, gene and novel therapies industrialized
11
worldwide labs with PBMC processing
20
cell therapy trials in the last 5 years
A precise and integrated approach to cell therapy development.
Specialized capabilities and proven expertise in cell therapy development helps compress timelines and find efficiencies in every stage. When your team is collaborating under one global roof, you find ways to work smarter and bring novel therapies to market faster.
-
Explore
Clinical Trial Design
- Full service CRO for global trials
- Patient recruitment and enrollment: specialization in rare disease
- Expertise with current regulatory environment
- Operational excellence in cell therapy study conduct
-
Explore
Specialty Lab Services
- Immune Monitoring
- Bioanalysis
- Genomics
- IHC/mIF and Pathology
- Liquid Biopsy
-
Explore
Manufacturing Solutions
- End-to-end services for the entire manufacturing life cycle
- Planning and designing
- Building and testing
- Deploying and operating
- Scalability and flexibility
- End-to-end services for the entire manufacturing life cycle
-
Explore
Biospecimens
- PBMCs—healthy and disease state
- Leukopaks
- Mobilized leukopaks
-
Explore
PBMC & Sample Processing
Sample processing with expertise in PBMC isolations from labs across 5 continents
-
Explore
CDx Development & Commercialization
- Biomarker discovery and assay development
- Preclinical planning and strategy
- Assay development into single-site PMA CDx with full regulatory and market support
Expertise in cell therapy trials
For cell therapy trials there is a keen demand for high-quality, efficient, well-run studies that enable teams to move rapidly in an iterative development cycle. Our experienced team recognizes the nuances involved and prepares trial strategies that address safety, site selection, training, patient recruitment and logistics.
Scientific capabilities support cell therapies in the lab
Precision supports cell therapy development with a complete suite of biomarker assay services including assay development, validation and implementation to support every phase of your cell therapy project. Our team includes thought leaders in immunogenicity testing that are helping shape the regulatory landscape.
Industrializing novel and complex therapies
Precision has vast experience in designing and building GMP-compliant cell and gene therapy facilities, using cutting-edge modular, emerging bioreactor, and single-use technologies. Our manufacturing playbook—which has been used by the leading cell and gene therapy organizations—has led to the development of the largest and most mature ATMP manufacturing footprint in the world.
6
in tech ops capital investments being managed
New Research Insights Into Cell Therapy
Top leadership ratings for a CRO in the ISR Report 2024
Discover how our cell therapy solutions can advance your innovation
Contact usOur latest insights on cell therapy development
FDA Approves Breakthrough Cell Therapy for Synovial Sarcoma
Manufacturing - Cell Therapies - Gene Therapies
Navigating Cell and Gene Therapy Acquisitions: A Strategic Blueprint
|